Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can needles protect your heart during surgery? new study says maybe

NCT ID NCT06110780

Symptom relief Sponsor: Kahramanmaras Sutcu Imam University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether electroacupuncture (using mild electric pulses through thin needles) can protect the heart and reduce inflammation in 104 people undergoing coronary artery bypass surgery. Researchers measured heart injury markers like troponin and inflammation levels. The goal was to see if this ancient technique, applied at specific points, could help patients recover better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
electroacupuncture
What this could lead to
If it works, this could offer a simple, drug-free way to help heart surgery patients recover with less heart damage and inflammation.
What could go wrong
This is a small, completed study with 104 participants, so results may not apply to everyone. Acupuncture effects can vary, and the study did not measure long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

104 people

The number who actually took part.

Started

Feb 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * American Society of Anesthesiologists (ASA) classification III, * 18-65 years old, * Conscious Open, * Participating in the study and giving permission to practice acupuncture, * Does not require emergency or repeat surgery, * Ejection/Fraction (E/F) ratio of 50-55% * Patients extubated within 24 hours after transfer to intensive care Exclusion Criteria: * Patients who do not want to participate in the study, * Patients with systemic diseases such as advanced liver, kidney and lung disease, * Those with chronic inflammatory diseases (rheumatoid arthritis and psoriasis), * Patients receiving immune systemic therapy, * Patients with poor mental status, * Patients with a history of epilepsy, * Patients with pacemakers, * Patients who have had heart surgery and emergency within the last month, * Patients with atrial fibrillation, * Patients who have atrial fibrillation and cannot be measured after coming off the pump, * Patients who were not extubated within 24 hours after transfer to intensive care were excluded from the study. * Additionally, patients receiving the antidiabetic sulfonylurea or glibenclamide were excluded because these agents have been shown to abolish the cardioprotective effect elicited by ischemic preconditioning.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Protective effects of acupuncture in cardiac surgery

Contacts and locations

Locations

  • Kahramanmaras Sutcu Imam University Faculty of Medicine

    Kahramanmaraş, 46040, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.